The baculoviral inhibitor of apoptosis protein repeat-containing 5 (BIRC5), also known as survivin, is a member of the inhibitor of apoptosis protein (IAP) family and also a target for cancer therapy [32] which exists at the crossroads of many cancer cell signaling networks. The gene discussed is BIRC5; the disease is cancer.